info@themedicimedicalresearch.com

+1 (954) 505-7480

Respiratory & Pulmonary

- Pulmonary Research Excellence at The Medici Medical Research

The Medici Medical Research offers deep expertise in respiratory and pulmonary clinical trials, serving both outpatient and acute-care populations. Led by experienced Principal Investigators with a background in internal medicine, our site has conducted numerous trials focused on chronic, inflammatory, and infectious pulmonary diseases.

Our trial portfolio includes:

  • Asthma – biologic and inhaled therapies for moderate-to-severe asthma, including long-term safety studies
  • Idiopathic Pulmonary Fibrosis (IPF) – anti-fibrotic therapy evaluation with imaging and pulmonary function endpoints
  • COPD (Chronic Obstructive Pulmonary Disease) – studies targeting exacerbation prevention and bronchodilator therapies
  • COVID-19 (Respiratory Phase) – outpatient treatment protocols assessing respiratory symptoms, oxygenation, and viral load
  • Cystic Fibrosis & Bronchiectasis – mucolytic, anti-inflammatory, and airway clearance interventions

The Medici Medical Research is equipped with spirometry testing, pulse oximetry, and staff trained in respiratory function assessments. Our site has successfully executed multi-phase respiratory trials with a focus on adherence, safety monitoring, and rapid enrollment.

With demonstrated quality, responsiveness, and clinical depth, we’ve earned recognition from multiple sponsors and CROs as a high-performing site in pulmonary research.